Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. YGEN.L Share Price
  4. YGEN.L Share Regulatory News
  5. Suspension

Pin to quick picksYGEN.L Regulatory News (YGEN)

YGEN.L Information
  • There is currently no data for YGEN

Suspension

15 Apr 2014 12:30

RNS Number : 8768E
ViaLogy PLC
15 April 2014
Β 

ο»Ώ

ViaLogy Plc

("Company")

Β 

Suspension

Β 

Β 

The Company notes the recent rise in its share price. The Company confirms that it is in discussions in relation to a possible transaction which, if completed, would constitute a reverse transaction pursuant to the AIM Rules. Consequently, the Company has requested that its shares are temporarily suspended with immediate effect, pending a further announcement.

Β 

Β 

Β 

Β 

Enquiries:

Β 

ViaLogy Plc

Mark Collingbourne

Β 

Β 

+44 1620 810 183

Β 

Cairn Financial Advisers LLP

Nomad

Liam Murray

Avi Robinson

Β 

Β 

Β 

+44 20 7148 7900

Β 

Panmure Gordon (UK) Limited

Broker

Robert Naylor

Freddy Crossley

Β 

Β 

+44 20 7886 2500

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCUVAARSKASAAR
6789101112131415
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud
6789101112131415

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
RWS
RWS Holdings
LSE
2.54%
THR
Thor Energy
LSE
0.00%
CMHY
CMHY.L
LSE
0.00%
JE.
Just Eat
LSE
0.00%
AGL
Angle
LSE
0.00%
Trending
GST
GSTechnologies
LSE
4.04%
PREM
Premier African Minerals
LSE
-2.78%
QED
Quadrise
LSE
1.01%
CPI
Capita
LSE
3.62%
NTVO
Nativo Resources
LSE
4.55%